DermBiont
DermBiont is a biotechnology company developing microbial therapeutics for the treatment of skin diseases. Its pipeline of topical therapeutic candidates includes DBI-001 for eczema, athlete’s foot, and nail fungus; DBI-002 for inflammatory dandruff; and SM-020 for benign skin tumors. By harnessing naturally occurring microbial communities, DermBiont aims to address the underlying microbial imbalances that…
Funding snapshot
About
DermBiont is a biotechnology company developing microbial therapeutics for the treatment of skin diseases. Its pipeline of topical therapeutic candidates includes DBI-001 for eczema, athlete’s foot, and nail fungus; DBI-002 for inflammatory dandruff; and SM-020 for benign skin tumors. By harnessing naturally occurring microbial communities, DermBiont aims to address the underlying microbial imbalances that contribute to common dermatological conditions, offering alternatives to traditional steroid and antifungal treatments. Founded in 2015 and headquartered in Melrose, Massachusetts, the company has raised approximately $78.9 million in Series B funding from investors including Zola Global, Toba Capital, Viking Global Investors, Civilization Ventures, Illumina, Pivotal bioVenture Partners, Joyance Partners, and Massachusetts Biomedical Initiatives.
Business model
Metabolic Diseases > Drugs > Diversified,
Dermatology > Drugs > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.